BRIEF-Amgen announces positive top-line results from phase 3 study
August 29, 2016 at 09:16 AM EDT
* Amgen announces positive top-line results from phase 3 study of prolia (denosumab) in patients receiving glucocorticoid therapy
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.